Tianyin's Dr. James Jiayuan Tong is Invited to Speak at the CFO China Summit 2011 on January 19, 2011 at the St. Regis Hotel, Beijing
BEIJING, Nov. 16, 2010 /PRNewswire-Asia-FirstCall/ -- Dr. James Jiayuan Tong, Chief Financial Officer, Chief Business & Development Officer and Director of Tianyin Pharmaceutical (NYSE Amex: TPI) is invited to present at CFO China Summit 2011 which will be held at the St. Regis Hotel at 21 Jianguome...
Tianyin Reports Record First Quarter Fiscal Year 2011 Financial Results
CHENGDU, China, Nov. 10, 2010 /PRNewswire-Asia-FirstCall/ -- Tianyin Pharmaceutical Co., Inc. (NYSE Amex: TPI), a pharmaceutical company that specializes in the patented biopharmaceutical, modernized traditional Chinese medicine, branded generics and other pharmaceuticals announced financial results...
Tianyin to Attend Brean Murray, Carret & Co. 2010 China Growth Conference on November 17 - 18, 2010
CHENGDU, China, Nov. 10, 2010 /PRNewswire-Asia-FirstCall/ -- Tianyin Pharmaceutical Co., Inc. (NYSE Amex: TPI), a pharmaceutical company that specializes in patented biopharmaceutical medicine, modernized traditional Chinese medicine, branded generics and other pharmaceuticals will attend Brean Murr...
Tianyin Pharmaceutical Co., Inc. to Host First Quarter of Fiscal Year 2011 Earnings Conference Call on Thursday, November 11, 2010 at 9:00 a.m. ET
CHENGDU, China, Nov. 8, 2010 /PRNewswire-Asia/ -- Tianyin Pharmaceutical Co., Inc., (NYSE Amex: TPI), a pharmaceutical company that develops, manufactures and sells patented biopharmaceutical, modernized traditional Chinese medicine, branded generics and other pharmaceuticals, today announced that t...
Tianyin to Attend Lazard Capital Markets 7th Annual Healthcare Conference on November 16 - 17, 2010
CHENGDU, China, Nov. 8, 2010 /PRNewswire-Asia-FirstCall/ -- Tianyin Pharmaceutical Co., Inc. (NYSE Amex: TPI), a pharmaceutical company that specializes in patented biopharmaceutical medicine, modernized traditional Chinese medicine, branded generics and other pharmaceuticals will attend Lazard Capi...
Tianyin to Attend 2010 Maxim Group Growth Conference in New York on November 18, 2010
CHENGDU, China, Nov. 2, 2010 /PRNewswire-Asia-FirstCall/ -- Tianyin Pharmaceutical Co., Inc. (NYSE Amex: TPI), a pharmaceutical company that specializes in patented biopharmaceutical medicine, modernized traditional Chinese medicine, branded generics and other pharmaceuticals will present at the 201...
Tianyin Reports Record Fiscal 2010 Financial Results
CHENGDU, China, Sept. 29 /PRNewswire-Asia/ -- Tianyin Pharmaceutical Co., Inc., (NYSE Amex: TPI), a biopharmaceutical company that specializes in patented biopharmaceutical, modernized traditional Chinese medicine ("TCM"), branded generics and other pharmaceuticals, announced the results of fisc...
Tianyin Pharmaceutical Co., Inc. to Host Fiscal Year 2010 Earnings Conference Call on Thursday, September 30, 2010 at 9:00 a.m. ET
CHENGDU, China, Sept. 28 /PRNewswire-Asia/ -- Tianyin Pharmaceutical Co., Inc., (NYSE Amex: TPI), a biopharmaceutical company that develops, manufactures and markets patented biopharmaceutical, modernized traditional Chinese medicine, branded generics and other pharmaceuticals, today announced t...
Tianyin Corporate Presentation Updated
CHENGDU, China, Sept. 24 /PRNewswire-Asia-FirstCall/ -- Tianyin Pharmaceutical Co., Inc. (NYSE Amex: TPI), a biopharmaceutical company that specializes in modernized traditional Chinese medicine, branded generics and other pharmaceuticals, publishes the updated corporate presentation which was prese...
Tianyin to Attend Rodman & Renshaw 2010 Annual Global Investment Conference at New York from September 12 - September 15
CHENGDU, China, Sept. 8 /PRNewswire-Asia-FirstCall/ -- Tianyin Pharmaceutical Co., Inc. (NYSE Amex: TPI), a biopharmaceutical company that specializes in patented biopharmaceutical medicine, modernized traditional Chinese medicine, branded generics will participate in the Rodman & Renshaw 2010 Annua...
Tianyin To Attend ROTH Fall Conference at Maui, Hawaii From September 1 - September 6
CHENGDU, China, Aug. 31 /PRNewswire-Asia-FirstCall/ -- Tianyin Pharmaceutical Co., Inc. (NYSE Amex: TPI), a biopharmaceutical company that specializes in patented biopharmaceutical medicine, modernized traditional Chinese medicine, branded generics will participate in the Roth Fall Conference from S...
Jiangchuan Macrolide Facility Update
CHENGDU, China, July 17 /PRNewswire-Asia/ -- Tianyin Pharmaceutical (NYSE Amex: TPI), a pharmaceutical company that specializes in patented biopharmaceutical, modernized traditional Chinese medicine and branded generics provides progress update on its Jiangchuan macrolide facility. The co...
Tianyin Promotes its Flagship Product Portfolio at the 45th 2010 National New Special Drugs Trade Fair in July at Beijing
CHENGDU, China, June 28 /PRNewswire-Asia/ -- Tianyin Pharmaceutical (NYSE Amex: TPI), a biopharmaceutical company that specializes in patented biopharmaceutical, modernized traditional Chinese medicine and branded generics will exhibit and promote its flagship product portfolio at the 45th 2010 ...
Tianyin Corporate Presentation Updated
CHENGDU, China, June 3 /PRNewswire-Asia/ -- Tianyin Pharmaceutical Co., Inc. (NYSE Amex: TPI), a biopharmaceutical company that specializes in modernized traditional Chinese medicine and branded generics publishes the updated corporate presentation at the Company's website: http://www.tia...
Tianyin to Present at the BMC 2010 Life Sciences Summit at New York on May 17
CHENGDU, China, May 17 /PRNewswire-Asia/ -- Tianyin Pharmaceutical Co., Inc. (NYSE Amex: TPI), a biopharmaceutical company that specializes in modernized traditional Chinese medicine ("TCM") and branded generics is invited to present at the Brean Murray Carret & Co. 2010 Life Sciences Summit in ...
Tianyin Reports Record Third Quarter 2010 Financial Results
CHENGDU, China, May 12 /PRNewswire-Asia-FirstCall/ -- Tianyin Pharmaceutical Co., Inc., (NYSE Amex: TPI), a biopharmaceutical company that specializes in the modernized traditional Chinese medicine ("TCM") and branded generics today announced fiscal results for its third quarter ended March 31, ...
Tianyin Pharmaceutical Co., Inc. to Host Third Fiscal Quarter 2010 Results Earnings Conference Call on Wednesday, May 12, 2010 at 9:00 a.m. ET
CHENGDU, China, May 8 /PRNewswire-Asia-FirstCall/ -- Tianyin Pharmaceutical Co., Inc., (NYSE Amex: TPI), a biopharmaceutical company that develops, manufactures and sells modernized traditional Chinese medicine ("TCM") and branded generics based in Chengdu, China, today announced that the seni...
Tianyin to Present at 5th Annual Biomedical Forum by Sino American BioPharmaceutical Association
CHENGDU, Sichuan, China, April 22 /PRNewswire-Asia-FirstCall/ -- Tianyin Pharmaceutical (NYSE Amex: TPI) was invited by Sino American Biopharmaceutical Association (SABPA) to present at its 5th Annual Biomedical Forum held at Irvine, California on April 24th, 2010. SABPA Biomedical forum foc...
Tianyin CFO/CBDO Dr. James J. Tong Invited to Attend Cold Spring Harbor Asia Conference Opening Ceremony and James Watson Cancer Symposium at Suzhou, China
SUZHOU, China, April 5 /PRNewswire-Asia/ -- Cold Spring Harbor Asia (CSHA) is the Asia hub of Cold Spring Harbor Laboratory (CSHL), which is headed by the DNA structure discover, Dr. James D. Watson and President and CEO of CSHL, Dr. Bruce Stillman, who spearhead the effort in molecular medicine a...
Tianyin Appoints Dr. James Jiayuan Tong as Chief Financial Officer and Chief Business & Development Officer
Dr. Tong Also Joins the Board Of Directors CHENGDU, China, March 29 /PRNewswire-Asia/ -- Tianyin Pharmaceutical Co., Inc., (NYSE Alternext: TPI), a manufacturer and supplier of modernized traditional Chinese medicine ("TCM") based in Chengdu, China, today announced that it has appointed J...
